跳至主要内容
临床试验/JPRN-jRCT1080224818
JPRN-jRCT1080224818已完成1 期

Randomized, parallel-group comparative study of JR-031 in infants with neonatal hypoxic ischemic encephalopathy (hereinafter referred to as nHIE) for which hypothermia therapy is indicated

JCR Pharmaceuticals Co., Ltd.0 个研究点目标入组 12 人开始时间: 2019年8月2日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 至 <= 1weeks old(—)
性别
All

入选标准

  • 1) An infant diagnosed with nHIE and receiving hypothermia therapy
  • 2) An infant whose parent (legal representative) provides written informed consent

排除标准

  • 1) An infant with congenital anomaly (e.g., autosomal chromosome anomaly, congenital heart disease, congenital malformation syndrome)
  • 2) An infant with severe intracranial hemorrhage as detected by cranial ultrasonography or CT
  • 3) An infant with severe infection (e.g., sepsis)
  • 4) An infant with hyperkalemia
  • 5) An infant whose parent has a history of serious drug allergy or hypersensitivity
  • 6) An infant whose mother was treated with another investigational drug or product within 10 months before delivery of the infant
  • 7) An infant whose mother was found to be positive for HBs antigen, HCV antibody, or HIV antibody or be serologically positive for syphilis during pregnancy
  • 8) An infant who, in the opinion of the investigator or subinvestigator, is not appropriate for the study

研究者

相似试验